Anika Therapeutics, Inc.
Anika Therapeutics Receives European CE Mark Approval for "ELEVESS Light"
Published in Medical Letter on the CDC and FDA, December 6th, 2009
Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair based on hyaluronic acid ("HA") technology, announced that it has received European CE Mark approval for "ELEVESS™ Light," the Company's latest aesthetic product used for the treatment of fine lines and facial wrinkles. ELEVESS Light will be distributed in the European market by the Company's current aesthetic dermatology distributors.
"This approval expands our aesthetic dermatology product family and paves the way for an early 2010 launch of 'ELEVESS Light' in the European Union and other geographies that provide approvals based on the CE mark," said Charles...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Inderscience Publishers
ICT fails to accelerate drug approvals - Aegate
Medicines Top Counterfeit Concern List in Europe - Consumers Call for Tougher Safety Measures - American Heart Association
American Heart Association Late-Breaking Clinical Trial Report: New Reversible Antiplatelet Drug no More Effective Than Irreversible One in PCI - Bariatrics
Scientists at Michigan State University describe research in bariatrics - Cancer Vaccines
Study Evaluating Effect of Zolinza(R) (vorinostat) on QTc Interval in Patients with Advanced Cancer Published in Clinical Cancer Research - Cardiology
Data on cardiology discussed by S. Soncin and colleagues - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
